Mice lacking a CDK inhibitor, p57(Kip2), exhibit skeletal abnormalities and growth retardation

Journal of Biochemistry

Volumn 127, Issue 1, 2000, Pages 73-83

  Takahashi, Katsuhiko ^a,c   Nakayama, Kei Ichi ^b   Nakayama, Keiko ^b  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Beckwith Wiedemann syndrome; CDK inhibitor; Cell cycle; Gene targeting; Oncosuppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CELL CYCLE G1 PHASE; CONTROLLED STUDY; FIBROBLAST; GROWTH RETARDATION; HYPOTHESIS; MOUSE; NONHUMAN; PHENOTYPE; SKELETON MALFORMATION; VAGINA ATRESIA;

ANIMALIA;

EID: 0033962393     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022586     Document Type: Article

References (51)

1. Hunter, T. and Pines, J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573-582
2. Sherr, C.J. (1994) G1 phase progression: cycling on cue. Cell 79, 551-555
3. El-Deiry, W.S., Tokin, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B., (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825
4. Gu, Y., Turck, C.W., and Morgan, D.O. (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710
5. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
6. Xiong, Y., Honnon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704
7. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J.R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98
8. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74
9. Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78, 59-66
10. Cip1 family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662
11. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649
12. Serrano, M., Hannon, G.J., and Beach, D. (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4. Nature 366, 704-707
13. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261
14. INK4/MTS2 related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939-2952
15. Hirai, H., Roussel, M.F., Kato, J.-Y., Ashmun, R.A., and Sherr, C.J. (1995) Novel Ink4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681
16. ink4. Mol. Cell. Biol. 15, 2682-2688
17. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163
18. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat. Genet. 11, 204-206
19. KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA 93, 3026-3030
20. Hoovers, J.M.N., Kalikin, L.M., Johnson, L.A., Alders, M., Redeker, B., Law, D.J., Bliek, J., Steenmen, M., Benedict, M., Wiegant, J., Lengauer, C., Taillon-Miller, P., Schlessinger, D., Edwards, M.C., Elledge, S.J., Ivens, A., Westerveld, A., Little, P., Mannens, M., and Feinberg, A.P. (1995) Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc. Natl. Acad. Sci. USA 92, 12456-12460
21. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat. Genet. 14, 171-173
22. KIP2 gene at 11p15.5. Oncogene 12, 1365-1368
23. Seizinger, B.R., Klinger, H.P., Junien, C., Nakamura, Y., Le Beau, M., Cavenee, W., Emanuel, B., Ponder, B., Naylor, S., Mitelman, F., Louis, D., Menon, A., Newsham, I., Decker, J., Kaelbling, M., Henry, I., and Deimling, Av. (1991) Report of the Committee on Chromosome and Gene Loss in Human Neoplasia. Cytogenet. Cell Genet. 58, 1080-1096
24. Koi, M., Johnson, L.A., Kalikin, L.M., Little, P.F.R., Nakamura, Y., and Feinberg, A.P. (1993) Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science 260, 361-364
25. Sait, S.N.J., Nowak, N.J., Singh-Kahlon, P., Weksberg, R., Squire, J., Shows, T.B., and Higgins, M.J. (1994) Localization of Bechwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5. Genes Chromosomes Cancer 11, 97-105
26. KIP2 gene and its analysis in the G401 Wilms' tumor assay. Cancer Res. 56, 1214-1218
27. Nakayama, K., Nakayama, K., Negishi, I., Kuida, K., Sawa, H., and Loh, D.Y. (1994) Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl Acad. Sci. USA 91, 3700-3704
28. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720
29. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684
30. Elliott, M., Bayly, R., Cole, T., Temple, I.K., and Maher, E.R. (1994) Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin. Genet. 46, 168-174
31. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-158
32. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11, 973-983
33. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J., and Kato, J.Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14, 2066-2076
34. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T., and Hannon, G.J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 522-557
35. Kip1. Cell 85, 721-732
36. Kip1-deficient mice. Cell 85, 733-744
37. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Monygomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221
38. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37
39. DeChiara, T.M., Robertson, E.J., and Efstratiadis, A. (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849-859
40. Lee, M.P., Hu, R.J., Johnon, L.A, and Feinberg, A.P. (1997) Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet. 15, 181-185
41. Leighton, P.A., Ingram, R.S., Eggenschwiler, J., Efstratiadis, A., and Tilghman, S.M. (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375, 34-39
42. Buiting, K., Saitoh, S., Gross, S., Dittrich, B., Schwartz, S., Nicholls, R.D., and Horsthemke, B. (1995) Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat. Genet. 9, 395-400
43. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, NmJ. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548
44. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561
45. Cobrinik, D., Lee, M.-H., Honnon, G., Mulligan, G., Bronson, R.T., Dyson, N., Harlow, E., Beach, D., Weinberg, R.A., and Jacks, T. (1996) Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10, 1633-1644
46. Lee, M.-H., Williams, B.O., Mulligan, G., Mukai, S., Bronson, R.T., Dyson, N., Harlow, E., and Jacks, T. (1996) Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632
47. Sicinski, P., Donaher, J.L., Parker, S.B., Li, T., Fazeli, A., Gardner, H., Haslam, S.Z., Bronson, R.T., Elledge, S.J., and Weinberg, R.A. (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630
48. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364-2372
49. Sicinski, P., Donaher, J.L., Geng, Y., Parker, S.B., Gardner, H., Park, M.Y., Pobker, R.L., Richards, J.S., McGinnis, L.K., Biggers, J.D., Eppig, J.J., Bronson, R.T., Elledge, S.J., and Weinberg, R.A. (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384, 470-474
50. Williams, B.O., Schmitt, E.M., Reminton, L., Bronson, R.T., Albert, D.M., Weinberg, R.A.., and Jacks, T. (1994) Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251-4259
51. Noguchi, E., Sekiguchi, T., Yamashita, K., and Nishimoto, T. (1993) Molecular cloning and identification of two types of hamster cyclin-dependent kinases: cdk2 and cdk2L. Biochem. Biophys. Res. Commun. 197, 1524-1529